SBFM · Company research
Sunshine Biopharma Inc. (SBFM): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| A CEO holding 89.5% of voting power approves warrant terms at Sunshine Biopharma (SBFM). - Stock Titan | A CEO holding 89.5% of voting power approves warrant terms at Sunshine Biopharma (SBFM). Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| A financial group reports voting power over 909,900 Sunshine Biopharma (SBFM) shares. - Stock Titan | A financial group reports voting power over 909,900 Sunshine Biopharma (SBFM) shares. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| 909,090 shares plus warrants underpin a reported stake in Sunshine Biopharma (SBFM). - Stock Titan | 909,090 shares plus warrants underpin a reported stake in Sunshine Biopharma (SBFM). Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Sunshine Biopharma Completes $6 Million Public Offering - The Globe and Mail | Sunshine Biopharma Completes $6 Million Public Offering The Globe and Mail | View source ↗ | The Globe and Mail | Oct 10, 2026 | neutral | 0 | 0.6 |
| SBFM Stock Pops As Sunshine Biopharma Pushes Antiviral, Generics - Timothy Sykes | SBFM Stock Pops As Sunshine Biopharma Pushes Antiviral, Generics Timothy Sykes | View source ↗ | Timothy Sykes | Oct 8, 2026 | neutral | 0 | 0.6 |
| SBFM Stock Attracts Traders As Antiviral And Generics Story Builds - StocksToTrade | SBFM Stock Attracts Traders As Antiviral And Generics Story Builds StocksToTrade | View source ↗ | StocksToTrade | Oct 8, 2026 | neutral | 0 | 0.6 |
| Sunshine Biopharma Inc. SEC Filing (Oct 8, 2026) - Stock Titan | Sunshine Biopharma Inc. SEC Filing (Oct 8, 2026) Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| Warrants for 200,000 shares feature in Alta’s amended Sunshine Biopharma (SBFM) stake report. - Stock Titan | Warrants for 200,000 shares feature in Alta’s amended Sunshine Biopharma (SBFM) stake report. Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| SBFM Stock Holds Support As Traders Eye Next Move - Timothy Sykes | SBFM Stock Holds Support As Traders Eye Next Move Timothy Sykes | View source ↗ | Timothy Sykes | Aug 9, 2026 | neutral | 0 | 0.6 |
| SBFM Stock Holds Support As Sunshine Biopharma Tightens Cash Control - StocksToTrade | SBFM Stock Holds Support As Sunshine Biopharma Tightens Cash Control StocksToTrade | View source ↗ | StocksToTrade | Aug 8, 2026 | neutral | 0 | 0.6 |
| SBFM Stock Slides As Traders Focus On Cash Runway And Volatility - StocksToTrade | SBFM Stock Slides As Traders Focus On Cash Runway And Volatility StocksToTrade | View source ↗ | StocksToTrade | Aug 7, 2026 | neutral | 0 | 0.6 |
| EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval - Yahoo Finance | EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval Yahoo Finance | View source ↗ | Yahoo Finance | Aug 4, 2026 | neutral | 0 | 0.6 |
| SBFM Forecast — Price Target — Prediction for 2027 - TradingView | SBFM Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Why Sunshine Biopharma (SBFM) Stock Dropped After Hours Today - Benzinga | Why Sunshine Biopharma (SBFM) Stock Dropped After Hours Today Benzinga | View source ↗ | Benzinga | May 29, 2026 | neutral | 0 | 0.6 |
| Sunshine Biopharma Stock Rallies On Canadian Approval For Generic Amoxicillin - Benzinga | Sunshine Biopharma Stock Rallies On Canadian Approval For Generic Amoxicillin Benzinga | View source ↗ | Benzinga | May 21, 2026 | neutral | 0 | 0.6 |
| Sunshine Biopharma (SBFM) rockets higher as traders focus on low-float dynamics after recent SEC financing filings - Quiver Quantitative | Sunshine Biopharma (SBFM) rockets higher as traders focus on low-float dynamics after recent SEC financing filings Quiver Quantitative | View source ↗ | Quiver Quantitative | May 18, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.